These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 33887362)

  • 1. A survey on patient preferences towards CIED implantation.
    Naraparaju V; Almnajam M; Joseph L; Vernon G; Wakefield D; Magnano AR; Tolat A
    Indian Pacing Electrophysiol J; 2021; 21(4):227-231. PubMed ID: 33887362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of same-day discharge versus overnight stay strategy following cardiac device implantations: a high-volume single-centre experience.
    Archontakis S; Oikonomou E; Sideris K; Laina A; Tirovola D; Paraskevopoulou D; Kostakis P; Doundoulakis I; Arsenos P; Ntalakouras I; Charitakis E; Gatzoulis K; Tsioufis K; Sideris S
    J Interv Card Electrophysiol; 2023 Mar; 66(2):471-481. PubMed ID: 36063282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Same-day CIED implantation and discharge: Is it possible? The E-MOTION trial (Early MObilization after pacemaker implantaTION).
    Budano C; Garrone P; Castagno D; Bissolino A; Andreis A; Bertolo L; Mazzini D; Bergamasco L; Marra S; Gaita F
    Int J Cardiol; 2019 Aug; 288():82-86. PubMed ID: 31031076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial pacemaker as a bridge for pacemaker-dependent patients undergoing explantation of infected cardiac implantable electronic devices.
    Al-Maisary SSA; Romano G; Karck M; De Simone R
    J Card Surg; 2019 Jun; 34(6):424-427. PubMed ID: 31017328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of cardiac implantable electronic device placement in public and private hospitals.
    Ganesan AN; Moore K; Horton D; Heddle W; McGavigan AD; Hossain S; Ali A; Hariharaputhiran S; Ranasinghe I
    Intern Med J; 2020 Oct; 50(10):1207-1216. PubMed ID: 31762133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bundled skin antiseptic preparation for complex cardiac implantable electronic device infection: a propensity-score matching cohort study.
    Chen HC; Lee WC; Chen YL; Tsai TH; Pan KL; Lin YS; Chen MC
    J Hosp Infect; 2019 Nov; 103(3):311-320. PubMed ID: 31449919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac implantable electronic device (CIED) infections are expensive and associated with prolonged hospitalisation: UK Retrospective Observational Study.
    Ahmed FZ; Fullwood C; Zaman M; Qamruddin A; Cunnington C; Mamas MA; Sandoe J; Motwani M; Zaidi A
    PLoS One; 2019; 14(1):e0206611. PubMed ID: 30601808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights.
    Voigt A; Shalaby A; Saba S
    Pacing Clin Electrophysiol; 2010 Apr; 33(4):414-9. PubMed ID: 19793359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of changing antiseptic skin preparation agent used for cardiac implantable electronic device (CIED) procedures on the risk of infection.
    Qintar M; Zardkoohi O; Hammadah M; Hsu A; Wazni O; Wilkoff BL; Tarakji KG
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):240-6. PubMed ID: 25224666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Burden and Risk Factors for Infection of Transvenous Cardiovascular Implantable Electronic Device: a Nationwide Cohort Study.
    Yang PS; Jeong J; You SJ; Yu HT; Kim TH; Sung JH; Lee SS; Park HD; Joung B
    Korean Circ J; 2019 Aug; 49(8):742-752. PubMed ID: 31074228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding complications during cardiac electronic device implantation in patients receiving antithrombotic therapy: is there any value of local tranexamic acid?
    Beton O; Saricam E; Kaya H; Yucel H; Dogdu O; Turgut OO; Berkan O; Tandogan I; Yilmaz MB
    BMC Cardiovasc Disord; 2016 Apr; 16():73. PubMed ID: 27105588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the COVID-19 pandemic on cardiac implantable electronic device implantation in China: Insights from 2 years of changing pandemic conditions.
    Cheng CD; Zhao S; Jiang J; Lin N; Li P; Ning XH; Zhang S
    Front Public Health; 2022; 10():1031241. PubMed ID: 36483238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac implantable electronic device and associated risk of infective endocarditis in patients undergoing aortic valve replacement.
    Østergaard L; Valeur N; Bundgaard H; Gislason G; Torp-Pedersen C; Eske Bruun N; Køber L; Fosbøl EL
    Europace; 2018 Oct; 20(10):e164-e170. PubMed ID: 29294002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased long-term mortality in patients with cardiovascular implantable electronic device infections.
    Rizwan Sohail M; Henrikson CA; Jo Braid-Forbes M; Forbes KF; Lerner DJ
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):231-9. PubMed ID: 25243484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of bacteremia in patients living with cardiovascular implantable electronic devices.
    DeSimone DC; Sohail MR
    Heart Rhythm; 2016 Nov; 13(11):2247-2252. PubMed ID: 27546815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pocket haematoma after cardiac electronic device implantation in patients receiving antiplatelet and anticoagulant treatment: a single-centre experience.
    Demir GG; Guler GB; Guler E; Güneş H; Kizilirmak F; Karaca İO; Omaygenç MO; Çakal B; Olgun E; Savur U; Ibisoglu E; Barutçu I; Kiliçaslan F
    Acta Cardiol; 2017 Feb; 72(1):47-52. PubMed ID: 28597740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction in new cardiac electronic device implantations in Catalonia during COVID-19.
    Arbelo E; Angera I; Trucco E; Rivas-Gándara N; Guerra JM; Bisbal F; Jáuregui-Abularach M; Vallés E; Martin G; Sbraga F; Tolosana JM; Linhart M; Francisco-Pascual J; Montiel-Serrano J; Pereferrer D; Menéndez-Ramírez D; Jiménez J; Elamrani A; Borrás R; Dallaglio PD; Benito E; Santos-Ortega A; Rodríguez-Font E; Sarrias A; González-Matos CE; Martí-Almor J; Cabrera S; Mont L
    Europace; 2021 Mar; 23(3):456-463. PubMed ID: 33595062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex Differences in Acute Complications of Cardiac Implantable Electronic Devices: Implications for Patient Safety.
    Moore K; Ganesan A; Labrosciano C; Heddle W; McGavigan A; Hossain S; Horton D; Hariharaputhiran S; Ranasinghe I
    J Am Heart Assoc; 2019 Jan; 8(2):e010869. PubMed ID: 30648465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac implantable electronic devices with a defibrillator component and all-cause mortality in left ventricular assist device carriers: results from the PCHF-VAD registry.
    Cikes M; Jakus N; Claggett B; Brugts JJ; Timmermans P; Pouleur AC; Rubis P; Van Craenenbroeck EM; Gaizauskas E; Grundmann S; Paolillo S; Barge-Caballero E; D'Amario D; Gkouziouta A; Planinc I; Veenis JF; Jacquet LM; Houard L; Holcman K; Gigase A; Rega F; Rucinskas K; Adamopoulos S; Agostoni P; Biocina B; Gasparovic H; Lund LH; Flammer AJ; Metra M; Milicic D; Ruschitzka F;
    Eur J Heart Fail; 2019 Sep; 21(9):1129-1141. PubMed ID: 31410955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
    Pecha S; Aydin MA; Yildirim Y; Sill B; Reiter B; Wilke I; Reichenspurner H; Treede H
    Europace; 2013 Aug; 15(8):1205-9. PubMed ID: 23426553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.